Anne Li November 3rd, 2017
The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research. A US study, carried out at The University of Texas and published in Science, suggests that looking at the communities of bacteria in the gut – called the microbiome – might help predict which melanoma patients would respond to a type of immunotherapy called anti-PD-1 therapy.
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-11-02-gut-bacteria-may-influence-response-to-cancer-immunotherapy
Post a comment